Real long shot of anything concrete regarding a BO. But I do think we may get some anecdotal information of their thought process and might even hear if BP has shown interest. I always thought Celgene was a good fit and they have a lot of ties between them. I read the Celgene conference call and they said several times they are looking at M&A to add to their pipeline. This is kinda how it works now. Let nanocaps spend $150-$500 developing a drug then buy them out. It takes the risk out for BF of spending capital with possible failure. So I do think this is a very viable outcome....just not sure if this happens until FDA approves. Good luck man!
The most value will be brought out by a sale.With completed P3 and FDA approval should be able to sell it in less then a year.Maybe some potential buyers from 2015 will come back with a fair offer. I have a feeling Evercore was unable to sell it because of low ball offfers at the time market cap was higher.This time around should be more attractive with an FDA approval. Let's hope they can sell it and end this nightmare. Lol.
News 
Market Data 
Discover 
